.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Julphar
Federal Trade Commission
Deloitte
Fish and Richardson
Novartis
Baxter
Boehringer Ingelheim
Accenture
Mallinckrodt

Generated: June 27, 2017

DrugPatentWatch Database Preview

RENOVUE-65 Drug Profile

« Back to Dashboard

What is the patent landscape for Renovue-65, and what generic Renovue-65 alternatives are available?

Renovue-65 is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in RENOVUE-65 is iodamide meglumine. There is one drug master file entry for this compound. Additional details are available on the iodamide meglumine profile page.

Summary for Tradename: RENOVUE-65

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list3
Patent Applications: see list20
Drug Prices:see details
DailyMed Link:RENOVUE-65 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
RENOVUE-65
iodamide meglumine
INJECTABLE;INJECTION017902-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Deloitte
Federal Trade Commission
Cerilliant
Moodys
Cipla
AstraZeneca
Fuji
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot